AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Abuzer Coskun, SBU Istanbul Bağcılar Training and Research Hospital, Emergency Medicine Clinic, Istanbul, Turkey.
Citation: Abuzer Coskun, Burak Demirci, Sevki Hakan Eren (2023), Platelet/Mpv and Neutrophil/Lymphocyte Ratio in Prediction of Three Vascular Disease and Bypass in Patients with Acute Coronary Artery Syndrome, J Thoracic Disease and Cardiothoracic Surgery, 4(2); DOI:10.31579/2693-2156/047
Copyright: © 2023 Abuzer Coskun, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 15 March 2023 | Accepted: 28 March 2023 | Published: 08 April 2023
Keywords: acute coronary syndrome; emergency department; platelet/mean platelate to volume ratio; neutrophil/lymphocyte ratio; bypass; three vessel disease
Acute coronary syndrome (ACS) is the most important reason for admission to the emergency department all over the world. It was aimed to evaluate the effects of Platelet/Mean Platelate Volume ratio (PMR) and Neutrophil/lymphocyte ratio (NLR) levels in terms of complications after ACS, triple vessel disease (TVD), bypass and mortality.
This cross-sectional cohort study included 913 patients over the age of 18, who were admitted to the emergency department with a pre-diagnosis of ACS and admitted to the clinic between January 2013 and December 2017. Three groups were formed according to the patients' ACS diagnoses. These groups were compared in terms of PMR and NLR values, bypass, TVD and mortality.
The mean age of 913 patients included in the study was 63.84±12.18 years and 346 (37.9%) were female. NLR of the patients was 3.81±4.26% and PMR was 31.0±8.63% (p=0.001). By-pass was presebt in 46 (33.1%) and TVD in 90 (64.7%) patients, both of which were most common in the NSTEMI group (p=0.001). Mortality was observed in 20 (14.4%) NSTEMI cases and 37 (9.9%) STEMI cases (p=0.001). The most common complication after ACS was ischemic heart failure (p=0.001). Gensini score of patients who underwent bypass was 70.11±56.96 points, left ventricular ejection fraction was 45.82±11.34%, NLR was 8.46±7.76%, and PMR was 35.74±2.70%, which was significantly higher than those without bypass (p=0.001). In the TVD group, NLR was 6.01±5.33% and PMR was 37.06±5.11%. It was found to be significantly higher than the group without TVD (p=0.001).
In patients with acute coronary syndrome, PMR and NLR values are fast, easy to apply, inexpensive and reliable laboratory tests in predicting bypass, triple-vessel disease and mortality.
Coronary artery disease is still the most common cause of both morbidity and mortality worldwide. Despite the developing treatment possibilities, the prolongation of the average life expectancy also increases the number of elderly patients and the number of recurrent cardiovascular patients [1]. Acute coronary syndromes (ACS) usually occur when coronary blood flow is interrupted in previously narrowed arteries by atherosclerosis [2].
Cellular events occurring in platelets, white blood cells, vascular endothelium, smooth muscle cells and macrophages are important components of atherogenesis [3]. ACS is caused by thrombus formed in the coronary arteries [4]. Thrombus formation by the adhesion and aggregation of platelets is followed by a stable coronary fibrin-thrombus formation with the activation of the coagulation system [3]. Circulating platelets are heterogeneous in size, density, and reactivity. Increased platelet reactivity causes shortening of bleeding time and increased platelet volume. Platelet size change occurs with an increase in megakaryocyte volume, which is accompanied by an increase in platelet production when platelet destruction rate increases [5]. Mean Platelet Volume (MPV) is a simple and reliable platelet measure index that correlates with the functional status of platelets. Some studies have revealed that MPV is a parameter independent of known risk factors such as recurrent myocardial infarctions, hypertension, dyslipidemia, increased fibrinogen and white blood cell count. High MPV levels have been found in atherothrombosis [6,7].
Chronic inflammation is present at every stage of the development of atherosclerosis. Leukocytes have a very important role in this inflammatory process. White blood cell has been studied as an inflammatory biomarker to predict outcomes in patients with coronary artery disease [8-10]. Neutrophils play a direct role in the initiation of plaque rupture [11]. White blood cell is a strong independent predictor of mortality in patients diagnosed with ACS [12]. It has been shown that the neutrophil/lymphocyte ratio (NLR) may be a systemic marker of inflammation in predicting the morbidity, mortality and risk of myocardial infarction in high-risk coronary artery disease [13].
In our study, we aimed to reveal the importance of platelet/MPV ratio (PMR) and NLR in the prediction of acute coronary syndrome in the evaluation of by-pass, three vessel disease and mortality.
Study design and population
This retrospective study included 913 patients over the age of 18 (346 women, mean age 63.84±12.18 years, range 22-94 years), who were admitted to the emergency department with chest pain between January 2013 and December 2017, and were hospitalized with the prediagnosis of acute coronary syndrome. The study was performed in accordance with the Declaration of Helsinki, after the approval of the local ethics committee.
In addition to patients with cerebrovascular disease, low coma score, hospitalized in the intensive care unit, taking psychiatric medication, acute liver failure, dialysis history due to acute renal failure, infections such as meningitis, encephalitis and acute tuberculosis, malignancy and pregnant patients; patients without angiography, ejection fraction, hemogram and biochemistry blood results were excluded from the study.
According to the acute coronary syndrome status of the patients, three groups were formed: unstable angina (UA), ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Patients with ST-elevation myocardial infarction were divided into seven groups according to inferior, posterior, anterior, lateral, high lateral, diffuse anterior myocardial infarction and absence of ST-elevation. Unstable patients were determined according to the Braunwald classification [14] and high-risk patients were included in the study.
The patients were divided into two groups according to whether they had triple vessel disease (TVD), mortality, atrial fibrillation and bypass operation. The patients were divided into 3 groups as right bundle branch block, left bundle branch block and no development of bundle branch block.
In terms of complications developing after acute coronary syndrome, patients were divided into 8 groups as ischemic heart failure, ventricular tachycardia, atrioventricular block, cardiac tamponade, pleural effusion, pulmonary edema, ventricular fibrillation and no complications.
Cardiac troponin I was evaluated first at the patient's arrival to the emergency department, and then at 6 and 24 hours. The troponin values taken were recorded as I, II, and III.
Laboratory Design
Cardiac troponin, hemogram and biochemical blood samples were taken at the time of admission to the emergency department. Hemogram blood was measured using Sysmex DI-60 CBC Analyzer (Istanbul, Turkey). Biochemistry blood was analyzed with the Beckman Coulter Automated AU-680 (Beckman Coulter, Inc., Fullerton, CA, USA). Hemogram and biochemistry results were studied in 45-60 minutes. Troponin I STAT Elecsys and Cobas e 411 Hitachi Roche analyzers was used to measure Troponin I levels. Troponin levels of the patients were measured at 0, 6 and 24 hours.
Three-vessel disease (TVD): It was defined as more than 50% occlusion of the right coronary artery, circumflex artery, and left anterior descending artery.
Gensini Scoring System (GS): GS was used to grade the extent and severity of atherosclerosis in the coronary arteries for all patients. A Gensini score between 1-20 was considered mild coronary atherosclerosis, and a score >20 was considered severe coronary atherosclerosis [15].
Coronary Angiography: All patients included in the study underwent coronary angiography. Coronary angiography was performed via the femoral or radial artery using the standard Judkins technique. Stenosis of ≥50% for the left main coronary artery and ≥70% for other epicardial vessels was considered as severe occlusive coronary artery disease. Gensini scores were calculated to determine the extent of coronary artery disease according to the angiography results of the patients.
Electrocardiography: 12-lead Electrocardiography was performed with Cardiofax ECG-9132K (Nihon Kohden, Tokyo, Japan) at the bedside during admission to the emergency department.
Echocardiography: Transthoracic echocardiography was performed with Philips Epiq 7 Ultrasound device and left ventricular ejection fractions were evaluated and recorded as a % value.
Data from this study were analyzed with the software package SPSS 20.0 (SPSS Inc., Chicago, IL, USA). Shapiro Wilk's was used to investigate the normal distribution of the variables. Since the variables did not come from a normal distribution, the Mann Whitney U test and Kruskal Wallis-H test were used when examining the differences between the groups. Chi-square analysis was applied when examining the relationships between nominal variable groups. Receiver operating characteristic (ROC) curve analysis of PMR and NLR values was also performed for sensitivity and specificity values of by-pass, triple vessel disease, and mortality. When interpreting the results, p<0>
The mean age of 913 patients included in the study was 63.84±12.18 years and 346 (37.9%) were female. The mean age of the patients was significant compared to the acute coronary syndrome groups (p=0.001). In addition, the gensini score was 32.2±38.63 points (p=0.001) and the left ventricular ejection fraction was 52.99±12.61% (p=0.001). In the lipid profile of the patients, triglyceride was not statistically significant. Whereas, cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) were significant. Patients' liver enzymes and creatine kinase were insignificant. Laboratory values resulted as, platelet 268.5±81.8 10^3/UL (p=0.001), MPV 8.69±1.30 fL (p=0.001), neutrophil 5.67±2.36 10^3/UL (p=0.001), Lymphocyte 2.04±0.98 10 ^3/UL (p=0.006), Neutrophil / Lymphocyte Ratio (NLR) 3.81±4.26% (p=0.001) and Platelet / MPV Ratio (PMR) 31.0±8.63% (p=0.001). In addition, the values of cardiac troponins at 0, 6 and 24 hours were statistically significant (Table 1).
| Acute Coronary Syndrome | |||||||
All patients n:913 mean±SD | UA n:399 mean±SD | STEMI n:375 mean±SD | NSTEMI n:139 mean±SD |
P-value | |||
| Basaline Characteristcis | |||||||
| Age, year | 63.84±12.18 | 61.7±12.77 | 64.82±11.75 | 67.32±10.41 | 0.001 | ||
| Sex, Female/Male | 346/567 | 149/250 | 139/236 | 58/81 | 0.598 | ||
| Gensini Score | 32.2±38.63 | 13.96±25.39 | 51.83±42.57 | 32.04±32.9 | 0.001 | ||
| Ejection Fraction (%) | 52.99±12.61 | 59.81±9.56 | 47.65±11.60 | 47.75±13.55 | 0.001 | ||
| Labaratory Finding | |||||||
Lipid profile | TG, mg/dl | 137.43±84.74 | 140.13±83.46 | 136.2±80.82 | 133.0±99.2 | 0.100 | |
| CHOL, mg/dl | 171.27±56.50 | 172.79±55.85 | 173.96±57.95 | 159.62±53.25 | 0.030 | ||
| HDL, mg/dl | 34.63±12.93 | 35.25±11.71 | 34.7±14.04 | 32.66±13.07 | 0.004 | ||
| LDL, mg/dl | 107.63±42.37 | 109.38±40.42 | 108.71±45.84 | 99.68±37.17 | 0.041 | ||
Biochemistry | BS, mg/dL | 133.31±56.22 | 111.96±27.75 | 144.36±67.81 | 164.75±59.9 | 0.001 | |
| AST, mg/dL | 25.74±15.65 | 24.51±13.25 | 26.69±17.43 | 26.68±16.77 | 0.566 | ||
| ALT, mg/dL | 22.48±19.02 | 21.63±16.53 | 23.35±21.35 | 22.58±19.09 | 0.952 | ||
| ALP, mg/dL | 94.41±50.51 | 91.82±43.3 | 96.71±56.73 | 95.64±51.95 | 0.950 | ||
| CK, U/L | 134.4±108.7 | 131.9±105.6 | 136.3±113.1 | 136.86±106.1 | 0.799 | ||
| CKMB, U/L | 33.7±27.6 | 31.61±23.58 | 35.35±30.1 | 35.22±30.87 | 0.176 | ||
Hemogram | Platelet, 10^3uL | 268.5±81.8 | 246.1±66.9 | 265.5±67.8 | 341.4±85.2 | 0.001 | |
| MCV, fL | 88.75±7.72 | 88.63±8.02 | 88.85±7.69 | 88.84±6.88 | 0.692 | ||
| MCH, pg | 29.34±2.31 | 29.27±2.4 | 29.45±2.22 | 29.24±2.27 | 0.273 | ||
| MCHC, g/dL | 32.87±0.75 | 32.83±0.77 | 32.95±0.75 | 32.91±0.71 | 0.598 | ||
| RDW, % | 15.0±2.32 | 15.04±2.4 | 15.01±2.34 | 14.87±1.98 | 0.927 | ||
| MPV, fL | 8.69±1.30 | 8.33±1.05 | 8.63±1.21 | 9.87±1.49 | 0.001 | ||
| Neutrophil, 10^3uL | 5.67±2.36 | 5.18±1.79 | 5.40±2.13 | 7.81±3.12 | 0.001 | ||
| Lymphocyte, 10^3uL | 2.04±0.98 | 2.11±0.99 | 2.05±1.0 | 1.82±0.91 | 0.006 | ||
| Neutrophil / Lymphocyte Ratio | 3.81±4.26 | 3.17±3.35 | 3.74±4.62 | 5.83±4.97 | 0.001 | ||
| Platelet / MPV Ratio | 31.0±8.63 | 29.9±8.64 | 30.87±8.65 | 34.53±7.56 | 0.001 | ||
Cardiac Troponins | Tn I-1 (0 h), ng/mL | 2.83±0.81 | 0.03±0.03 | 3.11±5.29 | 1.87±2.2 | 0.001 | |
| Tn I-2 (6 h) | 3.55±1.62 | 0.08±0.22 | 7.27±5.91 | 4.74±6.15 | 0.001 | ||
| Tn I-3 (24 h) | 3.23±0.58 | 0.15±0.33 | 17.1±14.6 | 9.87±13.02 | 0.001 | ||
UA: Unstable Angina, STEMI: ST Elevation Myocardial Infarction, NSTEMI: Non ST Elevation Myocardial Infarction, TG: Triglyceride, CHOL: Cholesterol, HDL: High-Density Lipoprotein, VDL: Low-Density Lipoprotein, BS: Blood sugar, AST: Aspartate Aminotransferase, ALT: Alanine Aminotransferase, ALP: Alkaline Phosphatase, CK: Creatine Kinase, CKMB: Creatine Kinase-MB, MCV:Mean Corpuscular Volume, MCH: Mean Corpuscular Hemoglobin, MCHC: Mean Corpuscular Hemoglobin Concentration, RDW: Red Cell Distribution Width, MPV: Mean Platelet Volume, Tn:Troponin, SD: Standard Deviation, h:hour.
Table 1: Basal and laboratory characteristics of patients with acute coronary syndrome
In the analysis of patients according to acute coronary syndrome groups, no significant relationship was found with gender (p=0.598). By-pass was present in 46 (33.1%) and TVD in 90 (64.7%) patients, both of which were most common in the NSTEMI group (p=0.001). Mortality was observed in 20 (14.4%) NSTEMI cases and 37 (9.9%) STEMI cases (p=0.001). Atrial fibrillation and right bundle branch block were common in NSTEMI (p=0.001), while left bundle branch block was common in unstable angina (p=0.001). In addition, the most common complication after acute coronary syndrome was ischemic heart failure. This was followed by pulmonary edema and ventricular tachycardia (p=0.001, Table-2).
| Acute Coronary Syndrome | |||||
UA n (%) | STEMI n (%) | NSTEMI n (%) | p-value | ||
| Gender | Female | 49(37.3) | 139(37.1) | 58(41.7) | 0.598 |
| Male | 250(62.1) | 236(62.9) | 81(58.3) | ||
| By-pass | No | 394(98.7) | 365(97.3) | 93(66.9) | 0.001 |
| Yes | 5(1.3) | 10(2.7) | 46(33.1) | ||
| Three-vessel Disease | No | 383(96) | 327(87.2) | 49(35.3) | 0.001 |
| Yes | 16(4) | 48(12.8) | 90(64.7) | ||
| Mortality | No | 396(99.2) | 338(90.1) | 119(85.6) | 0.001 |
| Yes | 3(0.8) | 37(9.9) | 20(14.4) | ||
| Atrial Fibrillation | No | 378(94.2) | 317(84.5) | 75(54) | 0.001 |
| Yes | 23(5.8) | 58(15.5) | 64(46) | ||
Branch Block | No | 300(75.2) | 255(68) | 83(59.7) |
0.001 |
| Right Bundle Branch Block | 17(4.3) | 41(10.9) | 41(29.5) | ||
| Left Bundle Branch Block | 82(20.6) | 79(21.1) | 15(10.8) | ||
Complication | No | 359(90) | 58(15.5) | 32(23) |
0.001 |
| Ischemic Heart Failure | 14(3.5) | 185(4.3) | 40(28.8) | ||
| Ventricular Tachycardia | 5(1.3) | 35(9.3) | 16(11.5) | ||
| Atrioventricular Block | 5(1.3) | 41(10.9) | 6(4.3) | ||
| Cardiac Tamponade | 6(1.5) | 8(2.1) | 11(7.9) | ||
| Pulmonary Edema | 8(2) | 36(9.6) | 18(12.9) | ||
| Pleural Effusion | 2(0.5) | 4(1.1) | 13(9.4) | ||
| Ventricular Fibrillation | 0 | 8(2.1) | 3(2.2) | ||
UA: Unstable Angina, STEMI: ST Elevation Myocardial Infarction, NSTEMI: Non ST Elevation Myocardial Infarction
Table 2: Chi-square analysis of acute syndrome groups with variables
In the analysis of patients who underwent bypass procedure, age 68.85±10.0 years (p=0.001), gensini score 70.11±56.96 points (p=0.001), left ventricular ejection fraction 45.82±11.34% (p=0.001), NLR 8.46±7.76% and PMR was 35.74±2.70% (p=0.001). It was found to be significantly higher than those who did not have by-pass.
The relationship with gender and mortality was insignificant. However, its association with atrial fibrillation, TVD, right bundle branch block, ischemic heart failure, ventricular tachycardia, pulmonary edema, and non-ST elevation acute coronary syndromes was significant (p=0.001, Table-3).
| Bypass | ||||
No n (%) | Yes n (%) | p-value | ||
| Age, year | 63.48±12.25 | 68.85±10.0 | 0.001 | |
| Gensini Skoru | 29.56±35.51 | 70.11±56.96 | 0.001 | |
| Ejeksiyon Fraksiyonu% | 53.51±12.55 | 45.82±11.34 | 0.001 | |
| Neutrophil / Lymphocyte Ratio | 3.47±3.68 | 8.46±7.76 | 0.001 | |
| Platelet / MPV Ratio | 30.67±8.80 | 35.74±2.70 | 0.001 | |
| Gender | Female | 321(37.7) | 25(41) | 0.350 |
| Male | 531(62.3) | 36(59) | ||
| Three-vessel Disease | No | 735(86.3) | 24(39.3) | 0.001 |
| Yes | 117(13.7) | 37(60.7) | ||
| Mortality | No | 799(93.8) | 54(88.5) | 0.097 |
| Yes | 53(6.2) | 7(11.5) | ||
| Atrial Fibrillation | No | 730(85.7) | 38(62.3) | 0.001 |
| Yes | 122(14.3) | 23(37.7) | ||
Branch Block | No | 608(71.4) | 30(49.2) |
0.001 |
| Right Bundle Branch Block | 77(9) | 22(36.1) | ||
| Left Bundle Branch Block | 167(19.6) | 9(14.8) | ||
Complication | No | 443(52) | 6(9.8) |
0.001 |
| Ischemic Heart Failure | 225(26.4) | 14(23) | ||
| Ventricular Tachycardia | 47(5.5) | 9(14.8) | ||
| Atrioventricular Block | 49(5.8) | 3(4.9) | ||
| Cardiac Tamponade | 17(2) | 8(13.1) | ||
| Pulmonary Edema | 58(5.6) | 14(23) | ||
| Pleural Effusion | 14(1.6) | 5(8.2) | ||
| Ventricular Fibrillation | 9(1.1) | 2(3.3) | ||
ST-Elevation Myocardial Infarction | No | 488(57.3) | 52(85.2) |
0.004 |
| İnferior MI | 146(17.1) | 3(4.9) | ||
| Posterior MI | 8(0.9) | 0 | ||
| Anterior MI | 144(16.9) | 4(6.6) | ||
| Lateral MI | 12(1.4) | 0 | ||
| Common Anterior MI | 42(4.9) | 2(3.3) | ||
| High Lateral MI | 12(1.4) | 0 | ||
MI: Myocardial Infarction
Table 3: Chi-square analysis with variables of patients to be bypassed
Age, gender, and left ventricular ejection fraction were not significant in the three-vessel disease analysis. Whereas, gensini score was 42.08±44.08 points (p=0.001), NLR 6.01±5.33% (p=0.001) and PMR 37.06±5.11% (p=0.001) were found to be significantly higher than the group without TVD. In addition, mortality was significant with atrial fibrillation, right bundle branch block, complications and STEMI (p=0.001, Table-4).
| Three-vessel Disease | ||||
No n (%) | Yes n (%) | p-value | ||
| Age, year | 63.64±12.29 | 64.78±11.61 | 0.422 | |
| Gensini Skoru | 30.28±37.15 | 42.08±44.08 | 0.001 | |
| Ejeksiyon Fraksiyonu% | 53.07±12.68 | 52.60±12.28 | 0.626 | |
| Neutrophil / Lymphocyte Ratio | 3.36±3.86 | 6.01±5.33 | 0.001 | |
| Platelet / MPV Ratio | 29.77±8.67 | 37.06±5.11 | 0.001 | |
| Gender | Female | 292(38.5) | 54(35.1) | 0.242 |
| Male | 467(61.5) | 100(64.9) | ||
| Mortality | No | 717(94.5) | 136(88.3) | 0.007 |
| Yes | 42(5.5) | 18(11.7) | ||
| Atrial Fibrillation | No | 663(87.4) | 105(68.2) | 0.001 |
| Yes | 96(12.6) | 49(31.8) | ||
Branch Block | No | 530(69.8) | 108(70.1) |
0.001 |
| Right Bundle Branch Block | 70(9.2) | 29(18.8) | ||
| Left Bundle Branch Block | 159(20.9) | 17(11) | ||
Complication | No | 409(53.9) | 40(26) |
0.001 |
| Ischemic Heart Failure | 183(24.1) | 56(36.4) | ||
| Ventricular Tachycardia | 37(4.9) | 19(12.3) | ||
| Atrioventricular Block | 44(5.8) | 8(5.2) | ||
| Cardiac Tamponade | 19(2.5) | 6(3.9) | ||
| Pulmonary Edema | 43(5.7) | 19(123) | ||
| Pleural Effusion | 13(1.7) | 6(3.9) | ||
| Ventricular Fibrillation | 11(1.4) | 0 | ||
ST-Elevation Myocardial Infarction | No | 433(57) | 107(69.5) |
0.005 |
| İnferior MI | 134(17.7) | 15(9.7) | ||
| Posterior MI | 4(0.5) | 4(2.6) | ||
| Anterior MI | 127(16.7) | 21(13.6) | ||
| Lateral Mı | 11(1.4) | 1(0.6) | ||
| Common Anterior MI | 38(5) | 6(3.9) | ||
| High Lateral MI | 12(1.6) | 0 | ||
MI: Myocardial Infarction
Table-4: Chi-square analysis of three vessel disease with variables
According to the ROC curve analysis of the patients, the optimal cut-off values of PMR and NLR (AUC: Area Under the Curve, 95% CL: 95% Confidence Interval) to determine the positivity of by-pass, TVD and mortality;
By-pass; NLR: Sensitivity 90.2% and specificity 78.4%; (AUC; 0.896, 95% CI; 0.869-0.924, p=0.001). PMR: Sensitivity 96.7% and specificity 81.2%; (AUC; 0.713, 95% CI; 0.676-0.749, p=0.001 (Figure 1).
Figure 1: ROC curve analysis according to Platelet/MPV and Neutrophil/Lymphocyte Ratio bypass positivity
TVD; NLR: Sensitivity 86.7% and specificity 77.4%; (AUC; 0.802, 95% CI; 0.752-0.852, p=0.001). PMR: sensitivity 83.3% and specificity 71.9%; (AUC; 0.703, 95% CI; 0.655-0.750, p=0.001 (Figure 2).
Figure 2: ROC curve analysis according to Platelet/MPV and Neutrophil/Lymphocyte Ratio three vessel disease positivity
Mortality; NLR: sensitivity 80.5% and specificity 76.3%; (AUC; 0.800, 95% CI; 0.764-0.836, p=0.001). PMR: sensitivity 84.4% and specificity 81.2%; (AUC; 0.787, 95% CI; 0.755-0.819, p=0.001 (Figure 3).
Figure 3: ROC curve analysis according to Platelet/MPV and Neutrophil/ymphocyte Ratio mortality positivity
Until recent years, there were separate studies with platelet, MPV, and NLR in acute coronary syndrome, but we could not find any study in the literature that evaluated PMR and NLR together. We showed that PMR and NLR levels in emergency department admissions are strongly associated with complications that may occur during and after ACS, TVD, bypass and mortality.
It is known that chronic inflammation plays a role in every step of the development of atherosclerosis, and many risk factors accelerate this inflammatory process. In recent years, NLR has been used to predict the development and prognosis of coronary artery disease. It has been shown that NLR can be a systemic marker of inflammation in predicting the morbidity, mortality and risk of myocardial infarction of high-risk coronary artery disease [16]. It has been shown that while the neutrophil count increases in acute coronary syndrome, the lymphocyte count decreases [17]. Neutrophils play a direct role in the initiation of plaque rupture [11]. Clinical studies have shown that neutrophils are activated in unstable angina and ACS [18,19].
It has been shown that an increase in neutrophil count is associated with worse angiographic results, large infarct area, and worse short-term prognosis in ACS [20-22]. NLR was previously shown as a prognostic marker in non-cardiac diseases [23]. It has also been used as a prognostic marker in patients undergoing percutaneous intervention [24]. It has been shown that increased neutrophil count is associated with worse angiographic outcomes [21], large infarct area [22], and worse short-term prognosis [23] in patients with ACS. It has been reported that NLR is an independent predictor of cardiovascular complications after primary coronary angiography [25,26]. The high rate was found to be compatible with the frequency of early and long-term complications [27]. In our study, patients with high NLR scores had a high gensini score, a high number of patients with critical stenosis, a low left ventricular ejection rate, and a high number of patients who underwent bypass. In addition, the complication rate after ACS was found to be significantly higher in patients with high NLR.
In the study in which the 30-day mortality including all etiologies was evaluated with the NLR values measured at admission of patients with acute coronary syndrome, mortality was observed at the rate of 4% in the low NLR group, 10% in the moderate NLR group, and 19% in the high NLR group at the end of the 30th day [28]. Tamhane et al. [29] evaluated
the NLR values of 2833 patients diagnosed with ACS at admission, and the 6-month mortality in hospital and all-cause mortality. High NLR was found to be an independent indicator of in-hospital and 6-month mortality. In another study, when patients were grouped as low, moderate, or high according to the GRACE score, it was reported that the highest mortality rates were found in patients with NLR>4.7 among these groups. In the study evaluating the relationship between NLR and in-hospital mortality, 2 (2.3%) patients in the low NLR group and 4 (4.8%) patients in the high NLR group died [30]. In our study, NLR was found to be closely related to gender, mortality, complications after ACS, and ACS groups. While NLR was low in the UA group with low inflammation, it was found to be high in the STEMI groups and NSTEMI. Patients with a high Gensini score and a low left ventricular ejection fraction had a poor prognosis and a high mortality rate. In addition, complications after ACS, TVD, bypass and mortality rates were found to be high in patients with NLR>4.7 and above. The sensitivity and specificity of NLR for bypass, TVD, and mortality were determined, respectively (sensitivity: 90.2%, 86.7%, 80.5%; specificity: 78.4%, 77.4%, 76.3%).
Activation and aggregation of platelets play an important role in the pathogenesis of ACS. It was observed that megakaryocyte activity in the bone marrow accelerated and the number of circulating platelets and MPV increased in patients before ACS [31,32]. The transformation of stable angina into ACS, rupture of the atherosclerotic plaque and attachment of thrombus play an important role. The increase in this aggregation ability of platelets is seen as an independent risk factor for the development of coronary artery disease [33-35]. Cameron et al. [36] found that the platelet volumes were higher and the platelet count decreased in patients with AMI compared to the controls. In addition, increased MPV is associated with poor prognosis in AMI [37,38]. In addition, Chu et al. [39] showed in their meta-analysis that there is a relationship between MPV and AMI. However, there is no study in the literature showing the relationship between MPV and infarct size. In our study, a significant relationship was found between MPV and ACS groups. Therefore, it was found to be significant in ACS and PMR. There was a relationship between by-pass, developing complications, TVD and mortality among the PMR ACS groups.
In some studies, no significant difference was found between the MPV values of male and female individuals. A definite relationship could not be obtained in studies comparing similar risk factors with platelet functions [40]. Similar results were found in our study. Studies have shown that the increase in platelet volume after acute ischemic events returns to normal in the following days. High values are associated with complications [41]. In our study, a correlation was found between PMR elevation and complications after ACS. Ischemic heart failure was the most common in all ACS groups.
Bath et al. [42] found that the DNA content of active megakaryocytes increased in the bone marrows of patients who died while waiting for coronary by-pass operation. Since it is consumed rapidly in acute coronary syndromes, platelets produced in the bone marrow are released into the circulation in large volume before they mature [43]. Platelets produced rapidly in the bone marrow have a larger mean volume. In addition, earlier consumption of small-volume platelets than large-volume platelets in coronary events may also be responsible for the increase in mean platelet volume [44]. Martin et al. [45] showed that increased mean platelet volume is a risk factor for cardiac death. As in the current study, increased mean platelet volume in ischemic heart disease was also demonstrated by Pizzuli et al. [46] and Senaran et al. [47]. Similar results were found in our study. Especially in patients with high PMR, bypass, TVD and mortality rates were significantly higher than in unstable patients.
In the angiographic evaluation, critical stenosis was detected in 159 patients (58.2%), and angiography of 52 patients (18.9%) was found to be normal. Puzzili et al. [48] found in their study that patients who required emergency angioplasty had higher MPV levels than those who did not. Smyth et al. [49] reported that MPV was significantly higher in patients with restenosis in patients who underwent successful single-vessel angioplasty, and that there may be a relationship between MPV and restenosis. Contrary to these studies, in which the angiographic appearance was evaluated with MPV, the MPVs of 377 patients in whom coronary angiograms were evaluated, the cases without coronary artery disease and the patients with one and two vessel disease were compared, and no significant difference was found [50]. Again, no difference was found in studies comparing MPVs of individuals with and without coronary artery disease risk factors [51,52]. In our study, PMR values were higher in patients with TVD and those who underwent bypass in ACS patients. We think that the above studies were performed under elective conditions, and the parameters obtained in the first 24 hours in the acute phase in our study were higher than they were. In addition, the sensitivity and specificity values of PMR for by-pass, TVD, and mortality, respectively, were determined in our study (sensitivity: 96.7%, 83.3%, 84.4%; specificity: 81.2%, 71.9%, 81.2%).
In this study, we found that PMR and NLR were elevated in ACS patients with TVD, bypass and mortality. PMR and NLR were low in the unstable angina group with low inflammation, whereas they were high in the STEMI and NSTEMI groups. This suggests that PMR and NLR values are correlated with the degree of atherosclerosis in ACS patients and are released due to inflammatory events occurring during ACS.
In patients with acute coronary syndrome, PMR and NLR values are laboratory tests that are easy to apply, inexpensive and statistically reliable, giving rapid results in predicting bypass, three vessel disease and mortality. Comprehensive studies with large patient populations are needed to support this view. We believe that when used routinely, it is a valuable parameter for the prophylactic treatment of bypass, three-vessel disease and mortality that may develop after ACS.
ACS: Acute coronary syndrome
PMR: Platelet/Mean Platelate Volume ratio
NLR: Neutrophil/lymphocyte ratio
TVD: Three vessel disease
UA: Unstable angina
STEMI: ST elevation myocardial infarction
NSTEMI: non ST elevation myocardial infarction
MPV: Mean Platelet Volume
GS: Gensini Scoring System
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
